May 14, 2020 / 11:39 AM / 14 days ago

BRIEF-Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020

May 14 (Reuters) - Helix Biopharma Corp:

* HELIX BIOPHARMA CORP. L-DOS47 PHASE I LUNG CANCER TRIAL DATA TO BE RELEASED AT ASCO 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below